Intervention not reported
Amino acids + vitamin C(1 RCT; 191 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
It is very uncertain whether the intervention changes amino acids + vitamin C(1 RCT; 191 participants) (very low certainty).
1 finding from 1 review
OR 1.76 [0.62, 5.53]
Studies not reported
Very low
Intervention not reported
Amino acids(1 RCT; 78 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
It is very uncertain whether the intervention changes amino acids(1 RCT; 78 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Amino acids(2 trials; 158 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Minor adverse events · erectile dysfunction in men with obstructive sleep apnoea
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor adverse events · erectile dysfunction in men with obstructive sleep apnoea
It is very uncertain whether continuous positive airway pressure (CPAP) changes minor adverse events compared with phosphodiesterase type 5 inhibitors (very low certainty).
1 finding from 1 review
Minor adverse events · erectile dysfunction in men with obstructive sleep apnoea
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Visual acuity · infantile nystagmus syndrome
1 finding from 1 review
Minor bleeding · adults with arrhythmias undergoing catheter ablation
It is very uncertain whether interrupted changes minor bleeding compared with uninterrupted anticoagulation therapy (very low certainty).
1 finding from 1 review
Minor bleeding ‐ not reported · ambulatory patients with multiple myeloma receiving immunomodulatory agents
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor bleeding · ambulatory patients with multiple myeloma receiving immunomodulatory agents
It is very uncertain whether aspirin (ASA) changes minor bleeding compared with low molecular weight heparin (LMWH) (very low certainty).
1 finding from 1 review
Minor bleeding ‐ not reported · ambulatory patients with multiple myeloma receiving immunomodulatory agents
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor bleeding · ambulatory patients with multiple myeloma receiving immunomodulatory agents
It is very uncertain whether vitamin K antagonist (VKA) changes minor bleeding compared with low molecular weight heparin (LMWH) (very low certainty).
1 finding from 1 review
Minor bleeding ‐ not reported · ambulatory patients with multiple myeloma receiving immunomodulatory agents
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor bleeding · ambulatory patients with multiple myeloma receiving immunomodulatory agents
It is very uncertain whether aspirin (ASA) changes minor bleeding compared with direct oral anticoagulants (DOAC) (very low certainty).
1 finding from 1 review
RR 5 [0.31, 79.94]
1 study · 8 participants
Very low
Minor bleeding · ambulatory patients with multiple myeloma receiving immunomodulatory agents
It is very uncertain whether aspirin (ASA) changes minor bleeding compared with vitamin K antagonist (VKA) (very low certainty).
1 finding from 1 review
Number of people with one or more isolates of P aeruginosa · children with cystic fibrosis
Summary of findings ‐ Prophylactic showed no clear difference in number of people with one or more isolates of P aeruginosa compared with 'as required' anti‐staphylococcal antibiotics (low certainty).
1 finding from 1 review
Adverse events: minor gastrointestinal symptoms · healthy people and healthy male physicians
Vitamin A leads to higher adverse events: minor gastrointestinal symptoms compared with placebo (high certainty).
1 finding from 1 review
Intervention not reported
Retinopathy of prematurity (stage ≥ 3) · preterm infants with low birth weight
The intervention showed no clear difference in retinopathy of prematurity (stage ≥ 3) (high certainty).
1 finding from 1 review
Intervention not reported
Retinopathy of prematurity (all stages or stage not reported) during initial hospital stay · preterm infants with low birth weight
It is very uncertain whether the intervention changes retinopathy of prematurity (all stages or stage not reported) during… (very low certainty).
1 finding from 1 review
Intervention not reported
Retinopathy of prematurity (stage ≥ 3) during initial hospital stay · preterm infants with low birth weight
It is very uncertain whether the intervention changes retinopathy of prematurity (stage ≥ 3) during initial hospital stay (very low certainty).
1 finding from 1 review